IBDEI1SI ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30405,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,30405,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,30406,0)
 ;;=Z85.47^^118^1508^24
 ;;^UTILITY(U,$J,358.3,30406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30406,1,3,0)
 ;;=3^Personal history of malignant neoplasm of testis
 ;;^UTILITY(U,$J,358.3,30406,1,4,0)
 ;;=4^Z85.47
 ;;^UTILITY(U,$J,358.3,30406,2)
 ;;=^5063424
 ;;^UTILITY(U,$J,358.3,30407,0)
 ;;=Z85.49^^118^1508^25
 ;;^UTILITY(U,$J,358.3,30407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30407,1,3,0)
 ;;=3^Personal history of malignant neoplasm of male genital organs
 ;;^UTILITY(U,$J,358.3,30407,1,4,0)
 ;;=4^Z85.49
 ;;^UTILITY(U,$J,358.3,30407,2)
 ;;=^5063426
 ;;^UTILITY(U,$J,358.3,30408,0)
 ;;=Z85.51^^118^1508^26
 ;;^UTILITY(U,$J,358.3,30408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30408,1,3,0)
 ;;=3^Personal history of malignant neoplasm of bladder
 ;;^UTILITY(U,$J,358.3,30408,1,4,0)
 ;;=4^Z85.51
 ;;^UTILITY(U,$J,358.3,30408,2)
 ;;=^5063428
 ;;^UTILITY(U,$J,358.3,30409,0)
 ;;=Z85.528^^118^1508^27
 ;;^UTILITY(U,$J,358.3,30409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30409,1,3,0)
 ;;=3^Personal history of malignant neoplasm of kidney NEC
 ;;^UTILITY(U,$J,358.3,30409,1,4,0)
 ;;=4^Z85.528
 ;;^UTILITY(U,$J,358.3,30409,2)
 ;;=^5063430
 ;;^UTILITY(U,$J,358.3,30410,0)
 ;;=Z85.79^^118^1508^28
 ;;^UTILITY(U,$J,358.3,30410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30410,1,3,0)
 ;;=3^Personal history of malignant neoplasm of lymphoid, hematpoetc & rel tiss
 ;;^UTILITY(U,$J,358.3,30410,1,4,0)
 ;;=4^Z85.79
 ;;^UTILITY(U,$J,358.3,30410,2)
 ;;=^5063437
 ;;^UTILITY(U,$J,358.3,30411,0)
 ;;=Z85.831^^118^1508^29
 ;;^UTILITY(U,$J,358.3,30411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30411,1,3,0)
 ;;=3^Personal history of malignant neoplasm of soft tissue
 ;;^UTILITY(U,$J,358.3,30411,1,4,0)
 ;;=4^Z85.831
 ;;^UTILITY(U,$J,358.3,30411,2)
 ;;=^5063445
 ;;^UTILITY(U,$J,358.3,30412,0)
 ;;=Z85.71^^118^1508^1
 ;;^UTILITY(U,$J,358.3,30412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30412,1,3,0)
 ;;=3^Personal history of Hodgkin lymphoma
 ;;^UTILITY(U,$J,358.3,30412,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,30412,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,30413,0)
 ;;=Z85.830^^118^1508^30
 ;;^UTILITY(U,$J,358.3,30413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30413,1,3,0)
 ;;=3^Personal history of malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,30413,1,4,0)
 ;;=4^Z85.830
 ;;^UTILITY(U,$J,358.3,30413,2)
 ;;=^5063444
 ;;^UTILITY(U,$J,358.3,30414,0)
 ;;=Z85.820^^118^1508^2
 ;;^UTILITY(U,$J,358.3,30414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30414,1,3,0)
 ;;=3^Personal history of malignant melanoma of skin
 ;;^UTILITY(U,$J,358.3,30414,1,4,0)
 ;;=4^Z85.820
 ;;^UTILITY(U,$J,358.3,30414,2)
 ;;=^5063441
 ;;^UTILITY(U,$J,358.3,30415,0)
 ;;=Z85.828^^118^1508^31
 ;;^UTILITY(U,$J,358.3,30415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30415,1,3,0)
 ;;=3^Personal history of malignant neoplasm of skin NEC
 ;;^UTILITY(U,$J,358.3,30415,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,30415,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,30416,0)
 ;;=Z85.840^^118^1508^32
 ;;^UTILITY(U,$J,358.3,30416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30416,1,3,0)
 ;;=3^Personal history of malignant neoplasm of eye
 ;;^UTILITY(U,$J,358.3,30416,1,4,0)
 ;;=4^Z85.840
 ;;^UTILITY(U,$J,358.3,30416,2)
 ;;=^5063446
 ;;^UTILITY(U,$J,358.3,30417,0)
 ;;=Z85.841^^118^1508^33
 ;;^UTILITY(U,$J,358.3,30417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30417,1,3,0)
 ;;=3^Personal history of malignant neoplasm of brain
